Delivery Order SPE2DB20D3103-SPE2DB24FP4R7

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4563855693 OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. The $3,117.65 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S medical supplies. The award, valued at $1,494.51, was made by the Defense Logistics Agency (DLA) through a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 3, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, identified as SPE2DB22D2206|SPE2DB25FFJ41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,290.35, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $1,221.51 and is for the delivery of 4567199444 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,347.31, is for the delivery of 4567640023 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,784.25 firm fixed price delivery order is for the supply of 4567340215 - OSELTAMIVIR PHOS 30 MG CAPSULE UD 10S, with a performance period through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no major subcontractors...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,092.85, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S medical supplies. The contract, valued at $1,884.96, is a delivery order with a firm fixed price and an ultimate completion date of January 18, 2024. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $10,623.96, is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,556.40, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a prescription drug. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4R7
    Delivery Order

This federal contract award, identified as SPE2DB20D3103|SPE2DB24FP4R7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,726.68, is a delivery order for the supply of 4565097631 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S.

The contract is a Firm Fixed Price arrangement, with a completion date of July 10, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the awardee for this contract, which is not designated with any set-aside requirements.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 10:11 AM